Is Pfizer thinking of buying Bristol-Myers Squibb, as the rumors go? CEO Ian Read hinted at the possibility during a first-quarter earnings call — but investors shouldn’t expect any immediate action, he cautioned. Read told shareholders on the call, “we … believe we have the ability, should the opportunity arise and should the value be there, to do a large deal.”… more

During the call, Pfizer mentioned several “discontinued projects.” These included projects from its CV and metabolism pipeline and from its neuroscience unit … more